ACHN

Achillion Pharmaceuticals, Inc.
ACHN

Overview Fund Activity
Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

127 hedge funds and large institutions have $415M invested in Achillion Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 38 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
-22
Holders Change %
-14.77%
% of All Funds
2.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
17
Increased
41
Reduced
38
Closed
36
Calls
$3.12M
Puts
$259K
Net Calls
+$2.87M
Net Calls Change
+$2.5M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.3M
2
AC
Armistice Capital
New York
+$15.9M
3
GPP
Great Point Partners
Connecticut
+$13.7M
4
Goldman Sachs
Goldman Sachs
New York
+$9.98M
5
Citadel Advisors
Citadel Advisors
Florida
+$7.94M

Top Sellers

1
O
OrbiMed
New York
-$23.5M
2
Morgan Stanley
Morgan Stanley
New York
-$16.7M
3
SCM
Sarissa Capital Management
Connecticut
-$7.42M
4
Renaissance Technologies
Renaissance Technologies
New York
-$4.85M
5
BI
BVF Inc
California
-$4.63M
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
26
Perceptive Advisors
New York
$3.71M – – –
ACH
27
ArrowMark Colorado Holdings
Colorado
$3.47M – – –
Renaissance Technologies
28
Renaissance Technologies
New York
$3.25M -$4.85M -1,306,568 -60%
DCM
29
DAFNA Capital Management
California
$3.22M -$297K -80,000 -8%
SDIC
30
South Dakota Investment Council
South Dakota
$3.09M – – –
TCIM
31
TIAA CREF Investment Management
New York
$2.96M +$1.61M +432,818 +119%
AG
32
Artal Group
Luxembourg
$2.78M – – –
Charles Schwab
33
Charles Schwab
California
$2.6M +$563K +151,659 +28%
RPAM
34
Rhenman & Partners Asset Management
Sweden
$2.48M – – –
CS
35
Candriam SCA
Luxembourg
$2.41M +$798K +215,000 +49%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.33M +$144K +38,850 +7%
TCM
37
Tekla Capital Management
Massachusetts
$2.29M – – –
SCM
38
Sarissa Capital Management
Connecticut
$1.86M -$7.42M -2,000,000 -80%
QI
39
QS Investors
New York
$1.67M -$112K -30,113 -6%
Stifel Financial
40
Stifel Financial
Missouri
$1.49M – – –
Bank of America
41
Bank of America
North Carolina
$1.35M -$292K -78,595 -18%
PAM
42
Panagora Asset Management
Massachusetts
$1.26M -$438K -117,995 -26%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$1.25M -$109K -29,411 -8%
Morgan Stanley
44
Morgan Stanley
New York
$1.21M -$16.7M -4,486,067 -93%
UBS Group
45
UBS Group
Switzerland
$1.13M +$771K +207,824 +214%
VEA
46
Virtus ETF Advisers
New York
$973K +$523K +141,020 +116%
PP
47
PDT Partners
New York
$825K +$825K +222,500 New
OAM
48
Oxford Asset Management
United Kingdom
$812K -$533K -143,633 -40%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$766K +$81.7K +22,017 +12%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$754K +$754K +203,287 New
1
2
3 4 5